Cellectar Biosciences, Inc. (CLRB) vs Kiora Pharmaceuticals, Inc. (KPRX)
A side-by-side comparison of Cellectar Biosciences, Inc. and Kiora Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLRB
Cellectar Biosciences, Inc.
$1.51HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
KPRX
Kiora Pharmaceuticals, Inc.
$2.50HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CLRB vs KPRX
growth of $100 · dividends reinvested · last 10yCLRB -100.0% (-55.5%/yr)KPRX -100.0% (-56.0%/yr)CLRB compounded faster over this window
CLRB KPRX
CLRB vs KPRX: by the numbers
- •CLRB is the larger company ($12M vs $11M market cap).
Metrics side by side
Valuation
| Metric | CLRB | KPRX |
|---|---|---|
| P/B ratio | 0.40 | 0.66 |
Profitability
| Metric | CLRB | KPRX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -74.73% | -65.18% |
| ROIC | -74.94% | -59.42% |
Growth (annualized)
| Metric | CLRB | KPRX |
|---|---|---|
| Total return CAGR (5Y) | -60.51% | -67.06% |
Frequently asked
- How have CLRB and KPRX total returns compared?
- Over the past 10 years, CLRB delivered -55.35% and KPRX delivered -55.97% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.